Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - February 2014

3rd Annual Medical Device Investigator Initiated Studies Conference

10 Feb 2014 - 11 Feb 2014 - Raleigh-Durham, NC, USA

Bookmark and Share

Throughout the Medical Device industry, corporations are actively engaging with healthcare professionals to develop and execute Investigator Initiated studies, as a method of further researching and developing new and existing product lines. These exciting research studies hold tremendous value for manufacturers as well as the industry, as they continue to explore new uses for products that will ultimately streamline and improve healthcare delivery. However, as research budgets have constricted over the past several years, as pressure for results has increased, and regulatory reporting requirements have come on-line, both healthcare professionals as well as manufacturers are working to understand how to mutually benefit from these studies in a new and increasingly challenging environment.

Throughout the conference program, attendees will have an opportunity to engage and learn from a wide variety of stakeholders, including not only industry veterans, but also representatives from academic institutions, all of whom will provide important insight and clarity into this dynamic topic. As with all Q1 Productions conference programs, bringing together a range of the stakeholders involved in the topic will ensue all questions are brought to the table and addressed, guaranteeing a high return on investment for time spent at the conference program.

Further information
Scientific News
When it Comes to Breast Cancer, Common Pigeon is No Bird Brain
If pigeons went to medical school and specialized in pathology or radiology, they’d be pretty good at distinguishing digitized microscope slides and mammograms of normal vs. cancerous breast tissue, a new study has found.
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos